Different Targeted Antibody-drug Conjugates For HER2 Ultra-low or No Expression Advanced Breast Cancer（GALAXY）
Clinical trial NCT05824325 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05824325
- Sponsor
- Fudan University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-14
- Primary completion
- 2025-04-10
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.